Dose-Escalated Radiotherapy ± Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
J. Clin. Oncol 2023 Apr 27;[EPub Ahead of Print], DJ Krauss, T Karrison, AA Martinez, G Morton, D Yan, DW Bruner, B Movsas, M Elshaikh, D Citrin, B Hershatter, JM Michalski, JA Efstathiou, A Currey, VS Kavadi, FL Cury, M Lock, A Raben, SA Seaward, A El-Gayed, JP Rodgers, HM SandlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.